rdf:type |
|
lifeskim:mentions |
umls-concept:C0021368,
umls-concept:C0024143,
umls-concept:C0035020,
umls-concept:C0035820,
umls-concept:C0087111,
umls-concept:C0151650,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-5-24
|
pubmed:abstractText |
Renal relapse in lupus nephritis has been shown to have ominous prognostic significance with the majority of patients progressing to doubling of serum creatinine (CRX2). However, not all patients do so. This report explores the roles of response of inflammation to therapy and of glomerular scarring and interstitial fibrosis and their potential reversal to outcome of renal relapse.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0085-2538
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2176-86
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12028458-Chronic Disease,
pubmed-meshheading:12028458-Creatinine,
pubmed-meshheading:12028458-Disease Progression,
pubmed-meshheading:12028458-Fibrosis,
pubmed-meshheading:12028458-Humans,
pubmed-meshheading:12028458-Hyalin,
pubmed-meshheading:12028458-Kidney,
pubmed-meshheading:12028458-Kidney Failure, Chronic,
pubmed-meshheading:12028458-Kidney Glomerulus,
pubmed-meshheading:12028458-Lupus Nephritis,
pubmed-meshheading:12028458-Prognosis,
pubmed-meshheading:12028458-Severity of Illness Index,
pubmed-meshheading:12028458-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.
|
pubmed:affiliation |
Hôpital Broussais and INSERM Unité 430, Hôpital St. Louis, and Hôpital Bichat, Paris, France. garyhillparis@aol.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|